Chronic lymphocytic leukemia (CLL) is a type of cancer affecting a type of white blood cell in the blood and bone marrow. It often progresses slowly and is diagnosed most often during routine ...

Chronic lymphocytic leukemia-- or CLL-- is a type of cancer ... to change the genetic code inside your cells that make white blood cells. Normally, these cells help your body fight infection ...

Leukemia is a group of cancers that develop in blood cells. CLL develops in a type of white blood cell called lymphocytes. The rapid division of lymphocytes can crowd out healthy blood cells.

Ibrutinib normalizes RBC aggregation in CLL, potentially reducing thrombotic risks by mitigating blood flow complications. Obinutuzumab/venetoclax combination does ...

Panelists discuss exciting updates on Bruton tyrosine kinase (BTK) inhibitors from the 2024 American Society of Hematology ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

Researchers observed an increase in both CXCR4 and CD5 levels as the cells progressed to later stages of the cell cycle, particularly in the S/G2/M phases.

Leukemia is a type of blood cancer caused by a rise in the number of white blood cells in your body. Many types of leukemia produce no obvious symptoms in the early stages. Leukemia red spots are ...

Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.

Treatment for CLL continues ... to have stem cells collected from the donor’s bloodstream. But some donors might have stem cells collected from their bone marrow. Some people might have stem cells ...